Invention Grant
- Patent Title: Oxazolidinone for treatment of infections with
-
Application No.: US18060823Application Date: 2022-12-01
-
Publication No.: US11896584B2Publication Date: 2024-02-13
- Inventor: Gyanu Lamichhane , J. Thomas Ippoliti
- Applicant: The Johns Hopkins University , University of St. Thomas
- Applicant Address: US MD Baltimore
- Assignee: THE JOHNS HOPKINS UNIVERSTY,UNIVERSITY OF ST. THOMAS
- Current Assignee: THE JOHNS HOPKINS UNIVERSTY,UNIVERSITY OF ST. THOMAS
- Current Assignee Address: US MD Baltimore; US MN St. Paul
- Agency: Casimir Jones, SC
- Agent Jeffrey W. Childers
- Main IPC: A61K31/4245
- IPC: A61K31/4245
Abstract:
The present invention is a method of treating or preventing Mycobacterium tuberculosis infection in a subject by administering to the subject an effective amount of oxazolidinone, specifically (N—(((S)-3-(dibenzo[b,e][1,4]dioxin-7-yl)-2-oxooxazolidin-5-yl)methyl)acetamide) or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof.
Public/Granted literature
- US20230099803A1 OXAZOLIDINONE FOR TREATMENT OF INFECTIONS WITH MYCOBACTERIUM TUBERCULOSIS Public/Granted day:2023-03-30
Information query
